Also known as SO-26776, SQ-26776, (Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid, Aztréonam, Azactam, Primbactam, 2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid
Aztreonam, sold under the brand name Azactam among others, is an antibiotic used primarily to treat infections caused by gram-negative bacteria such as Pseudomonas aeruginosa. This may include bone infections, endometritis, intra abdominal infections, pneumonia, urinary tract infections, and sepsis. It is given by intravenous or intramuscular injection or by inhalation.
{{Infobox drug | verifiedrevid = 458976305 | image = Aztreonam skeletal structure.svg | image_class = skin-invert-image | width = 250 | alt = | image2 = Aztreonam ball-and-stick model from xtal 2023 inversion.png | image_class2 = bg-transparent | width2 = 250
| tradename = Azactam, others | Drugs.com = | MedlinePlus = a687010 | pregnancy_AU = B1 | routes_of_administration = Intravenous, intramuscular, inhalation | ATC_prefix = J01 | ATC_suffix = DF01 | ATC_supplemental =
via Wikipedia infobox
via PubChem
via PubMed
via Wikidata sitelinks · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).